AGCM-22, a novel cetuximab-based EGFR-targeting antibody-drug-conjugate with highly selective anti-glioblastoma efficacy
-
Published:2024-03
Issue:
Volume:102
Page:117657
-
ISSN:0968-0896
-
Container-title:Bioorganic & Medicinal Chemistry
-
language:en
-
Short-container-title:Bioorganic & Medicinal Chemistry
Author:
Li DapengORCID,
Sun Xianyan,
Li Yiquan,
Shang Chao,
Dong Yuchao,
Zhao Renshuang,
Zhang Hang,
Wang Zihao,
Fan ShiyongORCID,
Ma Chengyuan,
Li Xiao